IMVT
Immunovant, Inc. · Healthcare
Chief Development Officer Julia G. Butchko sold $63K of Immunovant, Inc.
Sold$62,885
$36.25Price
1,735Shares
What IMVT did after the filing
- The stock from Fri, Oct 6 close, $36.23
- −6.7%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Nov 17 close.
Traded Thu, Oct 5. Filed Fri, Oct 6, 1:15 PM ET, during the session. Returns use the Oct 6 close and the Nov 17 close. Not investment advice.